Stay updated on Birinapant and Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Birinapant and Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Birinapant and Pembrolizumab in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA minor site version update (Revision: v3.3.2) was implemented, with no visible changes to the study record.SummaryDifference0.1%

- Check33 days agoChange DetectedA site-wide funding/operating status notice was removed from the page; this does not affect the trial details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedThe study status is updated to Terminated due to futility analysis, and enrollment has been stopped. The record now includes updated completion dates and results postings.SummaryDifference0.4%

- Check76 days agoChange DetectedMajor change: updated operating status notice and version to v3.2.0, replacing v3.1.0; outlines funding lapse effects and where to check details.SummaryDifference3%

- Check83 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

- Check98 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1. The Back to Top element has been removed.SummaryDifference0.2%

Stay in the know with updates to Birinapant and Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Birinapant and Pembrolizumab in Solid Tumors Clinical Trial page.